Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
261
-
Total shares
-
102M
-
Shares change
-
+1.63M
-
Total reported value, excl. options
-
$5.85B
-
Value change
-
+$106M
-
Put/Call ratio
-
0.52
-
Number of buys
-
116
-
Number of sells
-
-163
-
Price
-
$57.39
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q4 2017
281 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q4 2017.
DEXCOM INC - Common Stock (DXCM) has 261 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 102M shares
of 392M outstanding shares and own 26.04% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (9.99M shares), JANUS HENDERSON GROUP PLC (8.67M shares), WELLINGTON MANAGEMENT GROUP LLP (8.32M shares), Vanguard Group Inc (6.99M shares), FMR LLC (6.4M shares), BAILLIE GIFFORD & CO (5.55M shares), MORGAN STANLEY (3.98M shares), BlackRock Inc. (3.8M shares), BROWN ADVISORY INC (3.72M shares), and Capital World Investors (3.4M shares).
This table shows the top 261 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.